Item 8.01. OTHER EVENTS.
As previously announced, on November 14, 2020, Taubman Centers, Inc., a Michigan corporation (“TCO” or the “Company”), The Taubman
Realty Group Limited Partnership, a Delaware limited partnership (the “Taubman Operating Partnership” and, together with TCO, the “Taubman Parties”), Simon Property Group, Inc., a Delaware corporation (“Simon”), Simon Property Group, L.P., a Delaware
limited partnership (the “Simon Operating Partnership”), Silver Merger Sub 1, LLC, a Delaware limited liability company and wholly owned subsidiary of the Simon Operating Partnership (“Merger Sub 1”), and Silver Merger Sub 2, LLC, a Delaware limited
liability company and wholly owned subsidiary of Merger Sub 1 (“Merger Sub 2” and, together with Simon, the Simon Operating Partnership and Merger Sub 1, the “Simon Parties”), entered into an Amended and Restated Agreement and Plan of Merger (the
“merger agreement”), amending and restating the Agreement and Plan of Merger by and among the Taubman Parties and the Simon Parties, dated February 9, 2020 (the “original merger agreement”). Pursuant to the merger agreement, subject to the
satisfaction or waiver of certain conditions, Merger Sub 2 will be merged with and into the Taubman Operating Partnership (the “Partnership Merger”) and TCO will be merged with and into Merger Sub 1 (the “REIT Merger” and, together with the
Partnership Merger, the “Mergers”). In connection with the merger agreement, on December 4, 2020, TCO filed a definitive proxy statement (the “Proxy Statement”) with the U.S. Securities and Exchange Commission (the “SEC”).
In connection with the original merger agreement and/or the merger agreement and the transactions contemplated thereby, two purported
class action complaints are presently pending on behalf of TCO shareholders against the Taubman Parties and Simon Parties (in the case of one of the complaints) and members of TCO’s board of directors in the United States District Court for the
District of Delaware and the Circuit Court for the 6th Judicial Circuit, Oakland County, of the State of Michigan. The two complaints are captioned as follows: Post v. Taubman Centers, Inc., et al., No. 1:20-cv-00685-UNA (D. Del.) (the “Post Action”) and Elstein v. Taubman Centers, Inc., et
al., No. 2020-185008-CB (Oakland County Cir. Ct.) (the “Elstein Action” and, together with the Post Action, the “Shareholder Actions”). The Post Action alleges that the defendants named therein violated Sections 14(a) and 20(a) of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”), or were legally responsible for such alleged violations, because the proxy statement filed by TCO on May 29, 2020 allegedly omits or misstates certain material information. The
Elstein Action alleges that the defendants named therein breached their fiduciary duties to the putative class and TCO under Michigan law, including their duty to disclose all material facts in the Proxy Statement. The Elstein action additionally
asserts derivative claims for breach of fiduciary duty, including breach of a fiduciary obligation to cause TCO to completely disclose all material facts in the Proxy Statement so that plaintiff and TCO’s other public shareholders can make an
informed decision whether to vote their shares in favor of the merger. A copy of the complaint in the Elstein action (the “Elstein Complaint”) is attached hereto as Exhibit 99.1. The Shareholder Actions seek, among other things, injunctive relief
preventing the consummation of the Mergers, unspecified damages and attorneys’ fees. Similar, earlier shareholder actions filed in connection with the original merger agreement were voluntarily dismissed.
TCO believes that no supplemental disclosures are required under applicable law. However, TCO is making certain disclosures below that
supplement and revise those contained in the Proxy Statement. TCO denies that any of the defendants have committed or assisted others in committing any violations of law. Nothing in these supplemental disclosures shall be deemed an admission of the
legal necessity or materiality under applicable laws of any of the supplemental disclosures set forth herein.
The following supplemental disclosures should be read in conjunction with the Proxy Statement, which should be read in its entirety. To
the extent that information herein differs from or updates information contained in the Proxy Statement, the information contained herein supersedes the information contained in the Proxy Statement. Defined terms used but not defined herein have the
meanings set forth in the Proxy Statement. For clarity, new text within restated paragraphs from the Proxy Statement are highlighted with bold,
underlined text.
Supplemental Disclosures to the Proxy Statement Related to Shareholder Actions
The disclosure in the section entitled “Background of the Transaction” under the heading “Special Factors,” beginning
on page 20 of the Proxy Statement is hereby amended by:
Amending and restating the final paragraph beginning on page 35 as follows:
During the go-shop period, Lazard contacted 18 potential counterparties, consisting of 4 strategic parties and 14 financial sponsor
parties. The potential counterparties were selected based on, among other reasons, the perceived strategic fit of Taubman for such parties, the
potential ability of such parties to consummate an acquisition involving a company the size of Taubman, and the perceived interest level of such parties in pursuing a potential acquisition of Taubman. None of these parties entered into
a confidentiality agreement with Taubman or received non-public due diligence information about Taubman. In addition, none of these parties made an acquisition proposal with respect to Taubman. During the go-shop period, the Special Committee
regularly held meetings with representatives of Lazard and Kirkland to discuss updates regarding the go-shop process.
Amending and restating the fourth
paragraph on page 37 as follows:
On November 9, 2020, Paul Weiss sent a draft amendment to the original merger agreement to Kirkland and Wachtell Lipton. From November
9, 2020 until the execution of the merger agreement on November 14, 2020, the parties and their respective legal advisors exchanged numerous drafts of, and engaged in multiple discussions and negotiations (including discussions and negotiations
involving Judge Rosen) concerning the terms of, the potential amendments to the original merger agreement. These discussions were focused on, among
other things, the scope of the interim operating covenants, the conditions to closing and other provisions related to the conditionality of the transactions contemplated by the original merger agreement. The parties also discussed changing the
governing law of the merger agreement to the laws of the State of Delaware and the exclusive forum for disputes related to the merger agreement to the Delaware Court of Chancery. During this period of time the parties also negotiated
the potential amendments to the original JV agreement and the settlement agreement. The terms of the voting agreement are identical to those of the original voting agreement. From November 9, 2020 until the execution of the merger agreement on
November 14, 2020, Kirkland engaged in numerous conversations with members of the Special Committee regarding the terms of the potential amendments to the original merger agreement.
The disclosure in the section entitled “Opinion of Financial Advisor to the Special Committee” under the heading
“Special Factors,” beginning on page 46 of the Proxy Statement is hereby amended by:
Amending and restating the second paragraph under the heading “Miscellaneous” on page 53 as follows:
Lazard has not been engaged to
provide financial advisory services to Simon or Taubman or an entity known by Lazard to be an affiliate of Simon or Taubman during the last two years.
The disclosure in the section entitled “Certain Unaudited Prospective Financial Information” under the heading
“Special Factors,” beginning on page 63 of the Proxy Statement is hereby amended by:
Inserting a new footnote (9) to the table at the top of page 66 that reads as follows:
(9) Certain line items calculated in the November 2020 Projections were not calculated for the purposes of the
January 2020 Projections.
The disclosure in the section entitled “Changes to the Original Merger Agreement Pursuant to the Merger Agreement”
under the heading “The Merger Agreement,” beginning on page 88 of the Proxy Statement is hereby amended by:
Amending and restating the first paragraph under the heading “Changes to the Original Merger Agreement Pursuant to
the Merger Agreement” as follows:
The original merger agreement was amended and restated pursuant to the merger agreement to, among other things, (i) reduce the common
stock merger consideration to $43.00 from $52.50 in cash, in each case without interest and less any required withholding taxes, (ii) change the consideration that a minority partner of the Taubman operating partnership immediately prior to the
effective time of the Partnership Merger may receive in the Partnership Merger into the right to receive, for each Taubman OP unit held, at the election of such minority partner, the common stock merger consideration or 0.5703 new Simon OP units
instead of an election between the common stock merger consideration or 0.3814 new Simon OP units as provided in the original merger agreement (reflecting
the revised purchase price and Simon’s stock price at the time the merger agreement was signed), (iii) narrow the conditions to the closing, including eliminating the condition that Taubman not have suffered a material adverse effect
condition, and, with respect to Taubman and the Taubman operating partnership’s compliance with their obligations under the merger agreement and with respect to the accuracy of Taubman and the Taubman operating partnership’s representations and
warranties such that any failure by Taubman, the Taubman operating partnership or any of their respective subsidiaries to comply with their obligations under the merger agreement or any inaccuracy of a representation or warranty of Taubman or the
Taubman operating partnership that relates to matters that, as of the date of the merger agreement, were known by certain executive officers of Simon, had been alleged by the Simon parties in the merger litigation, or had been (A) included in
Taubman’s SEC filings as of November 14, 2020 or (B) subject to certain exceptions, included in any materials or documents provided by Taubman or the Taubman operating partnership to the Simon parties or their representatives, are not to be taken
into account for the purposes of determining whether the conditions to the Simon parties’ obligations to consummate the transactions contemplated by the merger agreement have been satisfied, (iv) provide that Taubman’s obligation to use commercially
reasonable efforts to operate its business in the ordinary course does not prohibit Taubman from adopting certain measures in response to the COVID-19 pandemic, (v) prohibit Taubman and its subsidiaries from declaring any dividends or other
distributions until the consummation of the mergers without the prior written consent of Simon, except for the declaration and payment by Taubman of dividends (A) required to be distributed pursuant to the limited partnership agreement of the Taubman
operating partnership or to maintain Taubman’s status as a REIT and (B) pursuant to the terms of the Taubman Series J Preferred Stock and the Taubman Series K Preferred Stock, (vi) provide that both Taubman’s obligation to use commercially reasonable
efforts to operate its business in the ordinary course and certain specific operating restrictions limiting Taubman and its subsidiaries’ activities will terminate if the Transactions contemplated by the merger agreement have not been consummated
within six business days after the date on which the Taubman shareholder approval has been obtained because of the Simon parties’ willful breach of the merger agreement (such willful breach to include failure by the Simon parties to consummate the
Transactions within one business day of the conditions to consummating the Transactions being satisfied), (vii) provide that if, at any time prior to the effective time of the REIT Merger, there is a claim brought by or against Taubman to enforce the
obligations of Simon to consummate the Transactions, or for money damages for Simon’s failure to consummate the Transactions, or to excuse Simon’s obligation to consummate the Transactions, or to assert Simon’s right to terminate the merger
agreement, the consideration to be paid in connection with the Transactions will be deemed to be $52.50 in cash, without interest and less any required withholding taxes, in the event that Simon has brought or pursued such claim, failed to consummate
the Transactions in breach of the merger agreement or to comply with the merger agreement in such a manner as to frustrate a condition to closing of the merger agreement that forms a basis for a claim by Simon that it is not obligated to consummate
the Transactions, or sought to terminate the merger agreement, in each case other than in good faith and (viii) change the governing law of the merger agreement from the laws of the State of Michigan to the laws of the State of Delaware (except to
the extent that the corporate laws of the State of Michigan are mandatorily applicable) and change the exclusive forum for disputes related to the merger agreement to the Delaware Court of Chancery.
The disclosure in the section entitled “Compensation of the Special Committee” under the heading
“Interests of Taubman’s Directors and Executive Officers in the Transactions,” beginning on page 68 of the Proxy Statement is hereby amended by:
Amending and restating the paragraph under the heading “Compensation of the Special Committee” on page
74 in its entirety as follows:
The Special Committee consists of four independent members of the Taubman Board, Mayree C. Clark, Michael J. Embler, Cia Buckley
Marakovits and Myron Ullman III. It is expected that each member of the Special Committee will receive compensation of $125,000 for such member’s service on the Special Committee.
These fees are not dependent on the closing of the Transactions or on the Special Committee’s or the Taubman Board’s approval of, or recommendations with respect to, the Transactions.